MedTrace Logo

Bioactive Glass as Bone Graft Substitute in Operative Treatment of Bone - a 10 Years Follow-up Study

NCT00935870 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 63

Last updated 2009-07-09

No results posted yet for this study

Summary

The main aim is to evaluate the long-term safety and bone healing in the operated area and to compare bioactive glass granules with autogenous bone as a filler material.

Conditions

  • Depressed Lateral Condyle Fracture
  • Benign Bone Tumour Cavity
  • Spinal Fusion

Interventions

DEVICE

Bioactive glass and/or autogenous bone

No intervention in the current study (10-year follow-up study)

Sponsors & Collaborators

  • Vivoxid Ltd

    lead INDUSTRY

Principal Investigators

  • Nina Lindfors, MD · Turku University Hospital/Helsinki University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2008-06-30
Completion
2009-02-28

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00935870 on ClinicalTrials.gov